Prophylactic Mesh Placement During Formation of an End-colostomy Reduces the Rate of Parastomal Hernia: Short-term Results of the Dutch PREVENT-trial : Annals of Surgery

Journal Logo

RANDOMIZED CONTROLLED TRIAL

Prophylactic Mesh Placement During Formation of an End-colostomy Reduces the Rate of Parastomal Hernia

Short-term Results of the Dutch PREVENT-trial

Brandsma, Henk-Thijs MD; Hansson, Birgitta M. E. MD, PhD; Aufenacker, Theo J. MD, PhD; van Geldere, Dick MD, PhD; Lammeren, Felix M. V. MD, PhD; Mahabier, Chander MD, PhD; Makai, Peter PhD; Steenvoorde, Pascal MD, PhD; de Vries Reilingh, Tammo S. MD, PhD; Wiezer, Marinus J. MD, PhD; de Wilt, Johannes H. W. MD, PhD; Bleichrodt, Robert P. MD, PhD; Rosman, Camiel MD, PhD On behalf of the Dutch Prevent Study group

Author Information
Annals of Surgery 265(4):p 663-669, April 2017. | DOI: 10.1097/SLA.0000000000001903

Abstract

Objective: 

The aim of this study was to investigate the incidence of parastomal hernias (PSHs) after end-colostomy formation using a polypropylene mesh in a randomized controlled trial versus conventional colostomy formation.

Background: 

A PSH is the most frequent complication after stoma formation. Symptoms may range from mild abdominal pain to life-threatening obstruction and strangulation. The treatment of a PSH is notoriously difficult and recurrences up to 20% have been reported despite the use of mesh. This has moved surgical focus toward prevention.

Methods: 

Augmentation of the abdominal wall with a retro-muscular lightweight polypropylene mesh was compared with the traditional formation of a colostomy. In total, 150 patients (1:1 ratio) were included. The incidence of a PSH, morbidity, mortality, quality of life, and cost-effectiveness was measured after 1 year of follow-up.

Results: 

There was no difference between groups regarding demographics and predisposing factors for PSH. Three out of 67 patients (4.5%) in the mesh group and 16 out of 66 patients (24.2%) in the nonmesh group developed a PSH (P = 0.0011). No statistically significant difference was found in infections, concomitant hernias, SF-36 questionnaire, Von Korff pain score, and cost-effectiveness between both study groups.

Conclusion: 

Prophylactic augmentation of the abdominal wall with a retromuscular lightweight polypropylene mesh at the ostomy site significantly reduces the incidence of PSH without a significant difference in morbidity, mortality, quality of life, or cost-effectiveness.

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid